Publikationen, an denen er mitarbeitet LUIS FRANCO VERA (52)

2024

  1. The Many Roads from Alternative Splicing to Cancer: Molecular Mechanisms Involving Driver Genes

    Cancers, Vol. 16, Núm. 11

2022

  1. Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One?

    Cancers, Vol. 14, Núm. 3

2021

  1. Epigenetic mechanisms are involved in the oncogenic properties of ZNF518B in colorectal cancer

    Cancers, Vol. 13, Núm. 6, pp. 1-19

2020

  1. Blockade of the trans-sulfuration pathway in acute pancreatitis due to nitration of cystathionine β-synthase

    Redox Biology, Vol. 28

  2. EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness

    Scientific Reports, Vol. 10, Núm. 1

  3. Pentoxifylline and oxypurinol: Potential drugs to prevent the “cytokine release (storm) syndrome” caused by SARS-CoV-2?

    Current Pharmaceutical Design, Vol. 26, Núm. 35, pp. 4515-4521

2019

  1. ZNF518B gene up-regulation promotes dissemination of tumour cells and is governed by epigenetic mechanisms in colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Role of epigenetic factors in the selection of the alternative splicing isoforms of human KRAS in colorectal cancer cell lines

    Oncotarget, Vol. 9, Núm. 29, pp. 20578-20589

2017

  1. Histone post-translational modifications and nucleosome organisation in transcriptional regulation: Some open questions

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 65-92

2016

  1. Epigenetic regulation of early-and late-response genes in acute pancreatitis

    Journal of Immunology, Vol. 197, Núm. 10, pp. 4137-4150

  2. In silico RNA-seq and experimental analyses reveal the differential expression and splicing of EPDR1 and ZNF518B genes in relation to KRAS mutations in colorectal cancer cells

    Oncology Reports, Vol. 36, Núm. 6, pp. 3627-3634

2015

  1. EGF-Induced acetylation of heterogeneous nuclear ribonucleoproteins is dependent on KRAS mutational status in colorectal cancer cells

    PLoS ONE, Vol. 10, Núm. 6

  2. Growth arrest specific 1 (Gas1) gene overexpression in liver reduces the in vivo progression of murine hepatocellular carcinoma and partially restores gene expression levels

    PLoS ONE, Vol. 10, Núm. 7

  3. Nucleosome-specific, time-dependent changes in histone modifications during activation of the early growth response 1 (Egr1) gene

    Journal of Biological Chemistry, Vol. 290, Núm. 1, pp. 197-208

2011

  1. Epigenetic transcriptional regulation of the growth arrest-specific gene 1 (Gas1) in hepatic cell proliferation at mononucleosomal resolution

    PLoS ONE, Vol. 6, Núm. 8

2010

  1. Factor binding and chromatin modification in the promoter of murine Egr1 gene upon induction

    Cellular and Molecular Life Sciences, Vol. 67, Núm. 23, pp. 4065-4077

  2. Ordered transcriptional factor recruitment and epigenetic regulation of tnf-α in necrotizing acute pancreatitis

    Cellular and Molecular Life Sciences, Vol. 67, Núm. 10, pp. 1687-1697

2009

  1. Pentoxifylline prevents loss of PP2A phosphatase activity and recruitment of histone acetyltransferases to proinflammatory genes in acute pancreatitis

    Journal of Pharmacology and Experimental Therapeutics, Vol. 331, Núm. 2, pp. 609-617

2008

  1. Glutamate cysteine ligase up-regulation fails in necrotizing pancreatitis

    Free Radical Biology and Medicine, Vol. 44, Núm. 8, pp. 1599-1609

2007

  1. Abscisic acid and desiccation-dependent expression of a novel putative SNF5-type chromatin-remodeling gene in Pisum sativum

    Plant Physiology and Biochemistry, Vol. 45, Núm. 6-7, pp. 427-435